Lincotek and Promimic have begun a strategic licensing agreement that adds Promimic’s HA^nano Surface technology to its service portfolio.

This new arrangement builds on the existing Nano Processing Inc. (NPI) joint venture between Promimic and Danco Medical, a Lincotek company. NPI processes implants with HA^nano Surface in the U.S. market.

The deal will let Lincotek offer HA^nano Surface directly to its customers. HA^nano Surface is a super-hydrophilic and bioactive surface treatment for orthopedic implants that improves device osseointegration through biomimicking nanometer-thin hydroxyapatite (HA) crystals. The surface treatment offers biocompatibility, early stability, faster healing, and long-term implant success, according to the company.

The agreement provides Promimic expanded reach into the global orthopedic market and lets them offer customers access to enhanced processing capabilities beyond surface treatments. The strategic partnership will first focus on the U.S. market but is worldwide in nature, letting the two companies grow together globally as new opportunities come up.

“The new strategic licensing agreement provides a perfect match for both companies,” said Magnus Larsson, CEO of Promimic. “Lincotek’s extensive experience and capabilities in the 3D printing of implants, combined with our innovative surface treatment, will enable us to modify complex geometries uniformly, including micro-porous structures and their internal surfaces. Adding the super hydrophilic properties of HAnano Surface to the implant, without clogging the pores, promotes faster and better on-growth, as well as in-growth of bone directly to the implant surface.”

“We are excited to further strengthen the strategic partnership between Lincotek and Promimic,” added Lincotek CEO Andrea Colombo. “With this partnership our customers will have easier and better access to the full potential of the HA^nano Surface technology, which will play a vital role in advancing implant technology for modern medical applications, ensuring implants are even better-performing and longer-lasting. Through this strengthened partnership, Lincotek and Promimic reaffirm their commitment to innovation in the medical industry, delivering next-generation solutions that improve patient outcomes and set new standards in implant surface technology.”